BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10962864)

  • 1. [Susceptibility to varicella-zoster virus infection, in pregnant adolescents of the Northern Area of Santiago, Chile].
    Martínez MJ; Peña M; Vergara R; Navarrete E
    Rev Med Chil; 2000 Apr; 128(4):447-8. PubMed ID: 10962864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of varicella zoster virus in pregnant patients].
    Sauerbrei A; Sonntag S; Wutzler P
    Zentralbl Gynakol; 1990; 112(4):223-6. PubMed ID: 2159681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
    Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
    Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroepidemiologic survey on varicella-zoster infection in the Province of Lecce].
    De Donno A; Guido M; Maiorano M; Zizza A; Tronci A; Gabutti G
    Ann Ig; 2001; 13(2):93-100. PubMed ID: 11414108
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
    Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
    Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus infection in pregnancy.
    Enders G
    Prog Med Virol; 1984; 29():166-96. PubMed ID: 6322232
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of hepatitis C virus antibodies in pregnant women in Santiago].
    Quero MS; Suarez M; Muñoz G; Torres M; Peña M
    Rev Med Chil; 1995 Jul; 123(7):907-8. PubMed ID: 8560124
    [No Abstract]   [Full Text] [Related]  

  • 11. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management.
    Karunajeewa H; Siebert D; Hammond R; Garland S; Kelly H
    Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):23-8. PubMed ID: 11284642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(951):55-7. PubMed ID: 7783692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Seroprevalence of varicella-zoster virus in children with cancer in six hospitals in Santiago, Chile].
    Izquierdo G; Zubieta M; Martínez G MJ; Alvarez AM; Aviles CL; Becker A; Peña M; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Santolaya ME;
    Rev Chilena Infectol; 2012 Dec; 29(6):595-9. PubMed ID: 23412026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history.
    Fung LW; Lao TT; Suen SS; Chan OK; Lau TK; Ngai KL; Chan PK; Leung TY
    Vaccine; 2011 Oct; 29(46):8186-8. PubMed ID: 21911021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difficulty in determining varicella-zoster immune status in pregnant women.
    Le CT; Lipson M
    Pediatr Infect Dis J; 1989 Sep; 8(9):650-1. PubMed ID: 2552391
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
    Chang CK; Tan HF; Tseng HF; Lin CC
    Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
    Chazan B; Colodner R; Teitler N; Chen Y; Raz R
    Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.